Drugs / recombinant human chorionic gonadotropin (r-hCG)
recombinant human chorionic gonadotropin (r-hCG)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01154192 | Aug 2011 → Jul 2014 | polycystic ovary syndrome | University of California, San Diego | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant human chorionic gonadotropin (r-hCG) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01154192 ↗ |
| Modality | Protein / enzyme biologic | “recombinant human chorionic gonadotropin” NCT01154192 ↗ |
| Route | Intravenous | “25ug of IV recombinant human chorionic gonadotropin (r-hCG)” NCT01154192 ↗ |